Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Chazan

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1988
Pharmacodynamics of salbutamol in humansR Chazan, W Droszcz, J E Maruchin
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|July 16, 1990
[The effect of salbutamol on histamine release from basophils in vivo and in vitro]R Chazan, E Wałajtys-Rode, P Droszcz
Pneumonologia I Alergologia Polska|December 19, 1998
[Treatment with salmeterol and quality of life in patients with asthma]J Wrońska, R Chazan, J Mazurek, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1992
Creatine kinase (CK) and creatine kinase isoenzyme (CK-MB) activity in serum before and after intravenous salbutamol administration of patients with bronchial asthmaR Chazan, W Tadeusiak, A Jaworski, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 17, 2009
Electrocardiographic changes in patients with spontaneous pneumothoraxR Krenke, J Nasilowski, T Przybylowski, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|October 1, 1995
[Effect of 16-week use of salmeterol on ECP levels, pulmonary function tests and bronchial hyperreactivity in patients with chronic obstructive lung disease]R Chazan, A Jaworski, H Grubek-Jaworska, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 6, 2001
CD4/CD8 lymphocytes in BALF during the efferent phase of lung delayed-type hypersensitivity reaction induced by single antigen inhalationH Grubek-Jaworska, G Hoser, P Droszcz, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1985
Changes in plasma high density lipoproteins (HDL) levels after salbutamolR Chazan, W Droszcz, D Bobilewicz, et al.
Folia Histochemica Et Cytobiologica|February 24, 2001
Expression of Fas antigen in the cells from bronchoalveolar lavage fluid (BALF)J Domagała-Kulawik, P Droszcz, I Kraszewska, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 1, 1995
[Correlation of ECP levels in sputum and blood with parameters of airflow obstruction and hyperreactivity in patients with irreversible bronchial obstruction due to chronic bronchitis]R Chazan, A Jaworski, H Grubek-Jaworska, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1988
Pharmacodynamics of salbutamol in humansR Chazan, W Droszcz, J E Maruchin
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|July 16, 1990
[The effect of salbutamol on histamine release from basophils in vivo and in vitro]R Chazan, E Wałajtys-Rode, P Droszcz
Pneumonologia I Alergologia Polska|December 19, 1998
[Treatment with salmeterol and quality of life in patients with asthma]J Wrońska, R Chazan, J Mazurek, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1992
Creatine kinase (CK) and creatine kinase isoenzyme (CK-MB) activity in serum before and after intravenous salbutamol administration of patients with bronchial asthmaR Chazan, W Tadeusiak, A Jaworski, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 17, 2009
Electrocardiographic changes in patients with spontaneous pneumothoraxR Krenke, J Nasilowski, T Przybylowski, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|October 1, 1995
[Effect of 16-week use of salmeterol on ECP levels, pulmonary function tests and bronchial hyperreactivity in patients with chronic obstructive lung disease]R Chazan, A Jaworski, H Grubek-Jaworska, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 6, 2001
CD4/CD8 lymphocytes in BALF during the efferent phase of lung delayed-type hypersensitivity reaction induced by single antigen inhalationH Grubek-Jaworska, G Hoser, P Droszcz, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1985
Changes in plasma high density lipoproteins (HDL) levels after salbutamolR Chazan, W Droszcz, D Bobilewicz, et al.
Folia Histochemica Et Cytobiologica|February 24, 2001
Expression of Fas antigen in the cells from bronchoalveolar lavage fluid (BALF)J Domagała-Kulawik, P Droszcz, I Kraszewska, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 1, 1995
[Correlation of ECP levels in sputum and blood with parameters of airflow obstruction and hyperreactivity in patients with irreversible bronchial obstruction due to chronic bronchitis]R Chazan, A Jaworski, H Grubek-Jaworska, et al.
Pageof 8